Income Taxes (Details Narrative) - CoNCERT Pharmaceuticals, Inc [Member] - License Rights [Member] |
Mar. 19, 2018
USD ($)
|
|---|---|
| Entity Listings [Line Items] | |
| Deferred tax liability | $ 3,037,147 |
| Intangible assets, financial reporting basis | 11,038,929 |
| Intangible assets, tax basis | $ 1,782 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences from financing arrangements. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences from tax deferred revenue or income classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|